The present application describes sulfonylaminovalerolactams and derivatives thereof of Formula I: ##STR00001## or pharmaceutically acceptable salt forms thereof, wherein ring G is a mono- or bicyclic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.